Home health agencies that bill for osteoporosis drugs for Medicare beneficiaries should consult new information on the topic.
MLN Matters article MM11846 reviews new codes, effective in January, for injectable osteoporosis drugs. See the article, which has a link to the relevant transmittal, at www.cms.gov/files/document/mm11846.pdf